Report date: Sept 1,2026
Conflict count: 380922
Publisher: Bioscientifica
Title count: 7
Conflict count: 404


==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9231780
CauseID: 1760879895
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Baum,4,3,237,1997,Tamoxifen
DOI: 10.1677/erc.0.0040237(Journal) (9231780-N)
DOI: 10.1677/erc.0.0403237(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231781
CauseID: 1760879899
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Sainsbury,4,3,251,1997,Timing of surgery and the ovarian cycle
DOI: 10.1677/erc.0.0040251(Journal) (9231781-N)
DOI: 10.1677/erc.0.0403251(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9231782
CauseID: 1760879904
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Leonard,4,3,245,1997,Tamoxifen toleration and toxicity
DOI: 10.1677/erc.0.0040245(Journal) (9231782-N)
DOI: 10.1677/erc.0.04030245(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231783
CauseID: 1760879909
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Leake,4,3,219,1997,Editorial
DOI: 10.1677/erc.0.0040219(Journal) (9231783-N)
DOI: 10.1677/erc.0.0403219(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231777
CauseID: 1760879768
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Berstein,2,2,171,1995,The endocrinology of large bowel cancer
DOI: 10.1677/erc.0.0020171(Journal) (9231777-N)
DOI: 10.1677/erc.0.0202171(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231778
CauseID: 1760879820
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Coombes,4,1,35,1997,The role of myoepithelial-derived growth factors in the human breast
DOI: 10.1677/erc.0.0040035(Journal) (9231778-N)
DOI: 10.1677/erc.0.0401035(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231779
CauseID: 1760879891
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Blamey,4,3,229,1997,The introduction of the LHRH agonist, Goserelin (Zoladex) into clinical practice
DOI: 10.1677/erc.0.0040229(Journal) (9231779-N)
DOI: 10.1677/erc.0.0403229(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231804
CauseID: 1760879892
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Powles,4,3,255,1997,Chemoprevention of breast cancer using tamoxifen
DOI: 10.1677/erc.0.0040255(Journal) (9231804-N)
DOI: 10.1677/erc.0.0403255(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231805
CauseID: 1760879896
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Nicholson,4,3,297,1997,erbB signalling in clinical breast cancer: relationship to endocrine sensitivity
DOI: 10.1677/erc.0.0040297(Journal) (9231805-N)
DOI: 10.1677/erc.0.0403297(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9231806
CauseID: 1760879901
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Morton,4,3,331,1997,Phyto-oestrogens and breast cancer
DOI: 10.1677/erc.0.0040331(Journal) (9231806-N)
DOI: 10.1677/erc.0.0403331(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231800
CauseID: 1760879756
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Bootsma,2,4,281,1995,The clinical significance of somatostatin receptor expression in human breast cancer
DOI: 10.1677/erc.0.0020281(Journal) (9231800-N)
DOI: 10.1677/erc.0.0204281(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231801
CauseID: 1760879771
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Lang,2,3,215,1995,The role of genetic factors and gene products in prostate cancer metastasis
DOI: 10.1677/erc.0.0020215(Journal) (9231801-N)
DOI: 10.1677/erc.0.0203215(Journal)
==========================================================

Created: 2026-08-14 21:14:28
ConfID: 9231802
CauseID: 1760879774
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Huber,1,2,57,1994,Hormone replacement therapy, endocrine monitoring and cyst fluid investigations in patients who have had a breast cyst
DOI: 10.1677/erc.0.0010057(Journal) (9231802-N)
DOI: 10.1677/erc.0.0102057(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231803
CauseID: 1760879889
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Miller,4,3,307,1997,Uptake and synthesis of steroid hormones by the breast
DOI: 10.1677/erc.0.0040307(Journal) (9231803-N)
DOI: 10.1677/erc.0.0403307(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231796
CauseID: 1760879728
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Jordan,2,1,45,1995,Drug resistance to tamoxifen: mutant estrogen receptors as a potential mechanism of tamoxifen-stimulated tumor growth
DOI: 10.1677/erc.0.0020045(Journal) (9231796-N)
DOI: 10.1677/erc.0.0201045(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231797
CauseID: 1760879732
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Sutherland,2,1,87,1995,Cell cycle control by steroid hormones in breast cancer: implications for endocrine resistance
DOI: 10.1677/erc.0.0020087(Journal) (9231797-N)
DOI: 10.1677/erc.0.0201087(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231798
CauseID: 1760879734
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Nicholson,2,1,115,1995,Observations arising from the use of pure antioestrogens on oestrogen-responsive (MCF-7) and oestrogen growth-independent (K3) human breast cancer cells
DOI: 10.1677/erc.0.0020115(Journal) (9231798-N)
DOI: 10.1677/erc.0.0201115(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231799
CauseID: 1760879749
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Brinkmann,2,3,203,1995,Mutant androgen receptors in endocrine-related cancer
DOI: 10.1677/erc.0.0020203(Journal) (9231799-N)
DOI: 10.1677/erc.0.0203203(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231820
CauseID: 1760879826
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Muller,4,1,75,1997,Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer
DOI: 10.1677/erc.0.0040075(Journal) (9231820-N)
DOI: 10.1677/erc.0.0401075(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231821
CauseID: 1760879830
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Mackay,3,4,327,1996,Effects of the synthetic vitamin D analogue EB 1089 and tamoxifen on the growth of experimental rat mammary tumours
DOI: 10.1677/erc.0.0030327(Journal) (9231821-N)
DOI: 10.1677/erc.0.0304327(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231822
CauseID: 1760879834
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Powles,4,1,135,1997,Chemoprevention of breast cancer: why is tamoxifen not the answer?
DOI: 10.1677/erc.0.0040135(Journal) (9231822-N)
DOI: 10.1677/erc.0.0401135(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231823
CauseID: 1760879841
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Littrup,3,3,199,1996,Economics of prostate cancer screening: racial implications
DOI: 10.1677/erc.0.0030199(Journal) (9231823-N)
DOI: 10.1677/erc.0.03030199(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231816
CauseID: 1760879729
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Dowsett,2,1,1,1995,Editorial
DOI: 10.1677/erc.0.0020001(Journal) (9231816-N)
DOI: 10.1677/erc.0.0201001(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231817
CauseID: 1760879735
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Assikis,2,3,235,1995,A realistic assessment of the association between tamoxifen and endometrial cancer
DOI: 10.1677/erc.0.0020235(Journal) (9231817-N)
DOI: 10.1677/erc.0.0203235(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231818
CauseID: 1760879750
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Colston,2,3,187,1995,Vitamin D and breast cancer: the therapeutic potential of new vitamin D analogues
DOI: 10.1677/erc.0.0020187(Journal) (9231818-N)
DOI: 10.1677/erc.0.0203187(Journal)
==========================================================

Created: 2026-08-14 21:14:28
ConfID: 9231819
CauseID: 1760879757
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Duncan,1,2,27,1994,The effect of gross cystic disease fluid proteins on oestrogen synthesis in breast cancer cells
DOI: 10.1677/erc.0.0010027(Journal) (9231819-N)
DOI: 10.1677/erc.0.0102027(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231836
CauseID: 1760879731
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Dowsett,2,1,3,1995,Mechanisms of hormone response: a role for apoptosis
DOI: 10.1677/erc.0.0020003(Journal) (9231836-N)
DOI: 10.1677/erc.0.0201003(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231837
CauseID: 1760879733
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Helle,2,2,153,1995,Insulin-like growth factors in breast and prostatic cancer
DOI: 10.1677/erc.0.0020153(Journal) (9231837-N)
DOI: 10.1677/erc.0.0202153(Journal)
==========================================================

Created: 2026-08-14 21:14:28
ConfID: 9231838
CauseID: 1760879736
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Harlozinska,1,2,63,1994,Epidermal growth factor receptor expression in patients with ductal breast carcinoma. Comparison with clinicopathological factors and estrogen receptor status
DOI: 10.1677/erc.0.0010063(Journal) (9231838-N)
DOI: 10.1677/erc.0.0102063(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231839
CauseID: 1760879741
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Klemen,1,4,53,1994,Morphological and immunohistochemical study of typical and atypical carcinoids of the lung with clinico-pathological correlation
DOI: 10.1677/erc.0.0010053(Journal) (9231839-N)
DOI: 10.1677/erc.0.0104053(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231824
CauseID: 1760879845
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Gusterson,4,1,67,1997,Selective cell ablation in the mammary gland of transgenic mice
DOI: 10.1677/erc.0.0040067(Journal) (9231824-N)
DOI: 10.1677/erc.0.0401067(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231825
CauseID: 1760879849
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Religa,3,2,127,1996,An unusual case of metastatic thyroid follicular carcinoma
DOI: 10.1677/erc.0.0030127(Journal) (9231825-N)
DOI: 10.1677/erc.0.0302127(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9231852
CauseID: 1760879911
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Vessey,4,3,261,1997,Hormone replacement therapy and the risk of breast cancer: an overview
DOI: 10.1677/erc.0.0040261(Journal) (9231852-N)
DOI: 10.1677/erc.0.0403261(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9231848
CauseID: 1760879887
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Dowsett,4,3,313,1997,Aromatase inhibitors: current status and future applications
DOI: 10.1677/erc.0.0040313(Journal) (9231848-N)
DOI: 10.1677/erc.0.0403313(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231849
CauseID: 1760879894
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Cuzick,4,3,281,1997,The use of hormone replacement therapy for women with breast cancer: a trial in the advanced disease setting
DOI: 10.1677/erc.0.0040281(Journal) (9231849-N)
DOI: 10.1677/erc.0.0403281(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231850
CauseID: 1760879900
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Soutter,4,3,381,1997,Gynaecological advice to breast cancer specialists
DOI: 10.1677/erc.0.0040381(Journal) (9231850-N)
DOI: 10.1677/erc.0.0403381(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231851
CauseID: 1760879905
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Smith,4,3,221,1997,Sir George Thomas Beatson
DOI: 10.1677/erc.0.0040221(Journal) (9231851-N)
DOI: 10.1677/erc.0.0403221(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231844
CauseID: 1760879823
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Bravo,3,4,293,1996,Current perspectives in the diagnosis and management of pheochromocytoma
DOI: 10.1677/erc.0.0030293(Journal) (9231844-N)
DOI: 10.1677/erc.0.0304293(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231845
CauseID: 1760879832
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Merlo,4,1,55,1997,In mammary epithelial cells p53-mediated apoptosis in response to DNA damage is dependent on the agent and can be influenced by growth factors
DOI: 10.1677/erc.0.0040055(Journal) (9231845-N)
DOI: 10.1677/erc.0.0401055(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231846
CauseID: 1760879836
OtherID: 696940008
JT: Endocrine Related Cancer
MD: DeMayo,4,1,85,1997,How can studies on knockout mice help in our understanding of normal and abnormal breast development?
DOI: 10.1677/erc.0.0040085(Journal) (9231846-N)
DOI: 10.1677/erc.0.0401085(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231847
CauseID: 1760879838
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Bruchovsky,4,2,153,1997,Intermittent therapy for prostate cancer
DOI: 10.1677/erc.0.0040153(Journal) (9231847-N)
DOI: 10.1677/erc.0.0402153(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231840
CauseID: 1760879787
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Chen,3,3,217,1996,Additive in vivo growth-inhibitory effects of flutamide and finasteride on androgen-sensitive Shionogi 115 carcinoma
DOI: 10.1677/erc.0.0030217(Journal) (9231840-N)
DOI: 10.1677/erc.0.0303217(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231841
CauseID: 1760879792
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Hanna,4,2,191,1997,Salmon calcitonin-like immunoreactivity in human neuroendocrine tumours
DOI: 10.1677/erc.0.0040191(Journal) (9231841-N)
DOI: 10.1677/erc.0.0402191(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231842
CauseID: 1760879795
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Goluda,3,2,131,1996,Expression of epidermal growth factor receptor in adenomyosis foci
DOI: 10.1677/erc.0.0030131(Journal) (9231842-N)
DOI: 10.1677/erc.0.0302131(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231843
CauseID: 1760879819
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Bonney,3,2,113,1996,The role of progestins and antiprogestins in the treatment of breast cancer
DOI: 10.1677/erc.0.0030113(Journal) (9231843-N)
DOI: 10.1677/erc.0.0302113(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231860
CauseID: 1760879716
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Wilding,4,2,179,1997,Endocrine effects of gastrointestinal tumours
DOI: 10.1677/erc.0.0040179(Journal) (9231860-N)
DOI: 10.1677/erc.0.0402179(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231861
CauseID: 1760879907
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Leake,4,3,289,1997,Prediction of hormone sensitivity - the receptor years and onwards
DOI: 10.1677/erc.0.0040289(Journal) (9231861-N)
DOI: 10.1677/erc.0.0403289(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231856
CauseID: 1760879737
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Fuqua,2,1,19,1995,A role for estrogen-receptor variants in endocrine resistance
DOI: 10.1677/erc.0.0020019(Journal) (9231856-N)
DOI: 10.1677/erc.0.0201019(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231857
CauseID: 1760879744
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Johnston,2,1,105,1995,Change in oestrogen receptor expression and function in tamoxifen-resistant breast cancer
DOI: 10.1677/erc.0.0020105(Journal) (9231857-N)
DOI: 10.1677/erc.0.0201105(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231858
CauseID: 1760879770
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Howell,2,2,131,1995,Clues to the mechanisms of endocrine resistance from clinical studies in advanced breast cancer
DOI: 10.1677/erc.0.0020131(Journal) (9231858-N)
DOI: 10.1677/erc.0.0202131(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231859
CauseID: 1760879793
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Safe,4,1,113,1997,Environmental factors and breast cancer
DOI: 10.1677/erc.0.0040113(Journal) (9231859-N)
DOI: 10.1677/erc.0.0401113(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232004
CauseID: 1760879898
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Olt,4,4,447,1997,Hormone-producing tumors of the ovary
DOI: 10.1677/erc.0.0040447(Journal) (9232004-N)
DOI: 10.1677/erc.0.0404447(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232005
CauseID: 1760879902
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Marsden,4,3,269,1997,Hormone replacement therapy and breast cancer
DOI: 10.1677/erc.0.0040269(Journal) (9232005-N)
DOI: 10.1677/erc.0.0403269(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9232000
CauseID: 1760879828
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Furr,4,2,197,1997,Relative potencies of flutamide and 'Casodex'
DOI: 10.1677/erc.0.0040197(Journal) (9232000-N)
DOI: 10.1677/erc.0.0402197(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9232001
CauseID: 1760879831
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Hugosson,3,3,147,1996,Natural evolution of prostate cancer
DOI: 10.1677/erc.0.0030147(Journal) (9232001-N)
DOI: 10.1677/erc.0.0303147(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9232002
CauseID: 1760879835
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Streuli,4,1,45,1997,Control of apoptosis in breast epithelium
DOI: 10.1677/erc.0.0040045(Journal) (9232002-N)
DOI: 10.1677/erc.0.0401045(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232003
CauseID: 1760879890
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Fernandes,4,4,465,1997,Reversion of Walker 256 tumor cachexia by insulin treatment: possible mechanisms involved and perspectives for future research
DOI: 10.1677/erc.0.0040465(Journal) (9232003-N)
DOI: 10.1677/erc.0.0404465(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232020
CauseID: 1760879884
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Safe,4,4,477,1997,Reply to Drs Bradlow and Telang
DOI: 10.1677/erc.0.0040477(Journal) (9232020-N)
DOI: 10.1677/erc.0.0404477(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9232021
CauseID: 1760879893
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Stewart,4,3,223,1997,Ovarian ablation - the last 100 years
DOI: 10.1677/erc.0.0040223(Journal) (9232021-N)
DOI: 10.1677/erc.0.0403223(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232022
CauseID: 1760879897
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Howell,4,3,371,1997,Oestrogens, Beatson and endocrine therapy
DOI: 10.1677/erc.0.0040371(Journal) (9232022-N)
DOI: 10.1677/erc.0.0403371(Journal)
==========================================================

Created: 2026-08-14 21:14:28
ConfID: 9232016
CauseID: 1760879766
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Caraci,1,2,15,1994,Cationic categorization of breast cyst fluid and breast cancer risk
DOI: 10.1677/erc.0.0010015(Journal) (9232016-N)
DOI: 10.1677/erc.0.0102015(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9232017
CauseID: 1760879773
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Parish,1,4,19,1994,The role of proteolysis in tumour invasion and growth
DOI: 10.1677/erc.0.0010019(Journal) (9232017-N)
DOI: 10.1677/erc.0.0104019(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9232018
CauseID: 1760879712
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Krentz,3,4,341,1996,Cryotherapy of hepatic metastases and regional perfusion with low-dose streptozotocin in the management of metastatic malignant insulinoma
DOI: 10.1677/erc.0.0030341(Journal) (9232018-N)
DOI: 10.1677/erc.0.0304341(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9232019
CauseID: 1760879861
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Lee,3,3,171,1996,Neoadjuvant androgen ablation therapy prior to radical prostatectomy: results of a 3-year follow-up
DOI: 10.1677/erc.0.0030171(Journal) (9232019-N)
DOI: 10.1677/erc.0.0303171(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9232036
CauseID: 1760879783
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Miller,3,1,65,1996,Aromatase inhibitors
DOI: 10.1677/erc.0.0030065(Journal) (9232036-N)
DOI: 10.1677/erc.0.0301065(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9232037
CauseID: 1760879824
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Chuba,3,3,157,1996,Curative treatment of prostate cancer with the combination of radiation and hormone therapies
DOI: 10.1677/erc.0.0030157(Journal) (9232037-N)
DOI: 10.1677/erc.0.0303157(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9232038
CauseID: 1760879827
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Waxman,3,3,279,1996,Endocrine therapy of advanced carcinoma of the prostate
DOI: 10.1677/erc.0.0030279(Journal) (9232038-N)
DOI: 10.1677/erc.0.0303279(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9232056
CauseID: 1760879822
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Lakhani,4,1,93,1997,Is there a benign to malignant progression?
DOI: 10.1677/erc.0.0040093(Journal) (9232056-N)
DOI: 10.1677/erc.0.0401093(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9232057
CauseID: 1760879829
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Meyer-Pannwitt,2,4,311,1995,Is neuron-specific enolase a useful tumor marker in the diagnosis and follow-up of patients with abdominal neuroendocrine tumors?
DOI: 10.1677/erc.0.0020311(Journal) (9232057-N)
DOI: 10.1677/erc.0.0204311(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9232076
CauseID: 1760879840
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Yaich,2,4,293,1995,Analysis of the estrogen receptor (ER) gene, transcript and protein in ER-positive and -negative breast cancer cell lines
DOI: 10.1677/erc.0.0020293(Journal) (9232076-N)
DOI: 10.1677/erc.0.0204293(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9232077
CauseID: 1760879883
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Wakeling,4,3,351,1997,New targets for therapeutic attack
DOI: 10.1677/erc.0.0040351(Journal) (9232077-N)
DOI: 10.1677/erc.0.0403351(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232078
CauseID: 1760879886
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Bradlow,4,4,475,1997,'Environmental factors and breast cancer'
DOI: 10.1677/erc.0.0040475(Journal) (9232078-N)
DOI: 10.1677/erc.0.0404475(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232079
CauseID: 1760879903
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Gasparini,4,4,423,1997,Angiogenesis in endocrine-related cancers
DOI: 10.1677/erc.0.0040423(Journal) (9232079-N)
DOI: 10.1677/erc.0.0404423(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9232080
CauseID: 1760879906
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Bulbrook,4,3,285,1997,A retrospective view of androgen and corticoid metabolites in the aetiology and clinical course of breast cancer
DOI: 10.1677/erc.0.0040285(Journal) (9232080-N)
DOI: 10.1677/erc.0.0403285(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9232096
CauseID: 1760879844
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Dahia,2,4,267,1995,The molecular pathogenesis of adrenal tumours
DOI: 10.1677/erc.0.0020267(Journal) (9232096-N)
DOI: 10.1677/erc.0.0204267(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231876
CauseID: 1760879740
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Reed,1,2,7,1994,Gross cystic breast disease: overview and directions for future research
DOI: 10.1677/erc.0.0010007(Journal) (9231876-N)
DOI: 10.1677/erc.0.0102007(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231877
CauseID: 1760879746
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Számel,1,2,49,1994,Hormonal characterization and classification of breast cyst fluid in gross cystic mastopathy
DOI: 10.1677/erc.0.0010049(Journal) (9231877-N)
DOI: 10.1677/erc.0.0102049(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231878
CauseID: 1760879788
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Janknegt,3,3,285,1996,Primary hormo-chemotherapy in metastatic prostate cancer
DOI: 10.1677/erc.0.0030285(Journal) (9231878-N)
DOI: 10.1677/erc.0.0303285(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231879
CauseID: 1760879796
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Danza,3,2,137,1996,Isotopic dilution GC-MS measurement of 4-hydroxyandrostenedione in postmenopausal breast cancer
DOI: 10.1677/erc.0.0030137(Journal) (9231879-N)
DOI: 10.1677/erc.0.0302137(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231900
CauseID: 1760879910
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Sutherland,4,3,357,1997,Cyclin-dependent kinases as downstream targets of oestrogen action: potential prognostic indicators and therapeutic targets
DOI: 10.1677/erc.0.0040357(Journal) (9231900-N)
DOI: 10.1677/erc.0.0403357(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231896
CauseID: 1760879743
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Schrey,1,3,41,1994,Role of regulatory peptides in the control of breast cancer cell growth and function
DOI: 10.1677/erc.0.0010041(Journal) (9231896-N)
DOI: 10.1677/erc.0.0103041(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231897
CauseID: 1760879751
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: Milewicz,1,2,37,1994,Can patients with benign breast disease who are at high risk for breast cancer be identified using bombesin estimation?
DOI: 10.1677/erc.0.0010037(Journal) (9231897-N)
DOI: 10.1677/erc.0.0102037(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231898
CauseID: 1760879754
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Macaulay,2,1,97,1995,Breast cancer angiogenesis and tamoxifen resistance
DOI: 10.1677/erc.0.0020097(Journal) (9231898-N)
DOI: 10.1677/erc.0.0201097(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231899
CauseID: 1760879791
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Limonta,3,3,211,1996,LHRH as a growth-inhibitory factor in prostatic tumor cells: possible mechanism of action
DOI: 10.1677/erc.0.0030211(Journal) (9231899-N)
DOI: 10.1677/erc.0.0303211(Journal)
==========================================================

Created: 2026-08-14 21:14:28
ConfID: 9231916
CauseID: 1760879755
OtherID: 1442534249
JT: Endocrine Related Cancer
MD: Reed,1,1,43,1994,The influence of stress-related factors on the distribution of sex steroids in plasma; implications for endocrine-dependent cancers
DOI: 10.1677/erc.0.0010043(Journal) (9231916-N)
DOI: 10.1677/erc.0.0101043(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231940
CauseID: 1760879784
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Marsden,3,2,81,1996,Hormone replacement therapy and breast cancer
DOI: 10.1677/erc.0.0030081(Journal) (9231940-N)
DOI: 10.1677/erc.0.0302081(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231936
CauseID: 1760879759
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Rea,2,1,13,1995,Structure and function of the oestrogen receptor in relation to its altered sensitivity to oestradiol and tamoxifen
DOI: 10.1677/erc.0.0020013(Journal) (9231936-N)
DOI: 10.1677/erc.0.0201013(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231937
CauseID: 1760879762
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Clarke,2,1,59,1995,Cross-resistance and molecular mechanisms in antiestrogen resistance
DOI: 10.1677/erc.0.0020059(Journal) (9231937-N)
DOI: 10.1677/erc.0.0201059(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231938
CauseID: 1760879772
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Levin,2,1,111,1995,Functional expression of estrogen receptors in experimental and human mammary tumors
DOI: 10.1677/erc.0.0020111(Journal) (9231938-N)
DOI: 10.1677/erc.0.0201111(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231939
CauseID: 1760879775
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Anderson,2,3,227,1995,Oestrogen sulphotransferases in malignant and normal human breast tissue
DOI: 10.1677/erc.0.0020227(Journal) (9231939-N)
DOI: 10.1677/erc.0.0203227(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231964
CauseID: 1760879711
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Labrie,3,3,243,1996,History of LHRH agonist and combination therapy in prostate cancer
DOI: 10.1677/erc.0.0030243(Journal) (9231964-N)
DOI: 10.1677/erc.0.0303243(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231965
CauseID: 1760879714
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Nicholson,4,2,141,1997,Prostate cancer and endocrine therapy
DOI: 10.1677/erc.0.0040141(Journal) (9231965-N)
DOI: 10.1677/erc.0.0402141(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231966
CauseID: 1760879882
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Knabbe,4,3,341,1997,Endocrine aspects of autocrine and paracrine growth control within the breast
DOI: 10.1677/erc.0.0040341(Journal) (9231966-N)
DOI: 10.1677/erc.0.0403341(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231960
CauseID: 1760879794
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Pike,4,1,125,1997,A hormonal contraceptive approach to reducing breast and ovarian cancer risk: an update
DOI: 10.1677/erc.0.0040125(Journal) (9231960-N)
DOI: 10.1677/erc.0.0401125(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231961
CauseID: 1760879818
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Yamamoto,3,4,337,1996,The inhibitory effect of medroxyprogesterone acetate on steroid sulfatase in human uterine endometrial cancer cells
DOI: 10.1677/erc.0.0030337(Journal) (9231961-N)
DOI: 10.1677/erc.0.0304337(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231962
CauseID: 1760879842
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Gann,3,3,179,1996,Prostate-specific antigen screening for prostate cancer: issues involving test validity
DOI: 10.1677/erc.0.0030179(Journal) (9231962-N)
DOI: 10.1677/erc.0.0303179(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231963
CauseID: 1760879846
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Gleave,2,4,243,1995,Stromal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness
DOI: 10.1677/erc.0.0020243(Journal) (9231963-N)
DOI: 10.1677/erc.0.0204243(Journal)
==========================================================

Created: 2026-08-14 21:14:29
ConfID: 9231956
CauseID: 1760879760
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Manni,2,2,141,1995,The role of the polyamine pathway in breast cancer development, progression and proliferation. A possible target for antitumor therapy
DOI: 10.1677/erc.0.0020141(Journal) (9231956-N)
DOI: 10.1677/erc.0.0202141(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231957
CauseID: 1760879763
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Miller,2,1,73,1995,Aromatase inhibition: determinants of response and resistance
DOI: 10.1677/erc.0.0020073(Journal) (9231957-N)
DOI: 10.1677/erc.0.0201073(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231958
CauseID: 1760879786
OtherID: 696940008
JT: Endocrine Related Cancer
MD: de Keyzer,3,2,99,1996,Molecular aspects of the ectopic ACTH syndrome
DOI: 10.1677/erc.0.0030099(Journal) (9231958-N)
DOI: 10.1677/erc.0.0302099(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231959
CauseID: 1760879789
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Santen,3,1,1,1996,Estrogen synthesis inhibitors for breast cancer: an introductory overview
DOI: 10.1677/erc.0.0030001(Journal) (9231959-N)
DOI: 10.1677/erc.0.0301001(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231980
CauseID: 1760879715
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Russo,4,1,7,1997,Role of differentiation in the pathogenesis and prevention of breast cancer
DOI: 10.1677/erc.0.0040007(Journal) (9231980-N)
DOI: 10.1677/erc.0.0401007(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231981
CauseID: 1760879858
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Muratori,4,2,203,1997,Genistein induces a G2/M block and apoptosis in human uterine adenocarcinoma cell lines
DOI: 10.1677/erc.0.0040203(Journal) (9231981-N)
DOI: 10.1677/erc.0.0402203(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231982
CauseID: 1760879862
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Schulman,3,3,205,1996,Controversial aspects of neoadjuvant hormonal deprivation prior to radical prostatectomy
DOI: 10.1677/erc.0.0030205(Journal) (9231982-N)
DOI: 10.1677/erc.0.0303205(Journal)
==========================================================

Created: 2026-08-14 21:14:53
ConfID: 9231983
CauseID: 1760879908
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Hayward,4,3,233,1997,The Canadian study - 25 years on
DOI: 10.1677/erc.0.0040233(Journal) (9231983-N)
DOI: 10.1677/erc.0.0403233(Journal)
==========================================================

Created: 2026-08-14 21:14:28
ConfID: 9231976
CauseID: 1760879765
OtherID: 1431110043
JT: Endocrine Related Cancer
MD: ,1,2,5,1994,Editorial
DOI: 10.1677/erc.0.0010005(Journal) (9231976-N)
DOI: 10.1677/erc.0.0102005(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231977
CauseID: 1760879837
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Labrie,3,3,145,1996,Editorial
DOI: 10.1677/erc.0.0030145(Journal) (9231977-N)
DOI: 10.1677/erc.0.0303145(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231978
CauseID: 1760879847
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Reed,3,1,9,1996,The development of steroid sulphatase inhibitors
DOI: 10.1677/erc.0.0030009(Journal) (9231978-N)
DOI: 10.1677/erc.0.0301009(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231979
CauseID: 1760879710
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Rao,3,4,309,1996,Endocrine role in ovarian cancer
DOI: 10.1677/erc.0.0030309(Journal) (9231979-N)
DOI: 10.1677/erc.0.0304309(Journal)
==========================================================

Created: 2026-08-14 21:14:30
ConfID: 9231996
CauseID: 1760879764
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Osborne,2,1,53,1995,Tamoxifen metabolism as a mechanism for resistance
DOI: 10.1677/erc.0.0020053(Journal) (9231996-N)
DOI: 10.1677/erc.0.0201053(Journal)
==========================================================

Created: 2026-08-14 21:14:32
ConfID: 9231997
CauseID: 1760879817
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Anderson,4,1,23,1997,Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis
DOI: 10.1677/erc.0.0040023(Journal) (9231997-N)
DOI: 10.1677/erc.0.0401023(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231998
CauseID: 1760879821
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Luo,3,3,229,1996,Relative potencies of Flutamide and Casodex: preclinical studies
DOI: 10.1677/erc.0.0030229(Journal) (9231998-N)
DOI: 10.1677/erc.0.0303229(Journal)
==========================================================

Created: 2026-08-14 21:14:31
ConfID: 9231999
CauseID: 1760879825
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Leinonen,3,3,191,1996,Significance of free and bound prostate-specific antigen
DOI: 10.1677/erc.0.0030191(Journal) (9231999-N)
DOI: 10.1677/erc.0.03030191(Journal)
==========================================================

Created: 2026-08-14 21:14:54
ConfID: 9231984
CauseID: 1760879912
OtherID: 696940008
JT: Endocrine Related Cancer
MD: Purohit,4,3,323,1997,Paracrine control of oestrogen production in breast cancer
DOI: 10.1677/erc.0.0040323(Journal) (9231984-N)
DOI: 10.1677/erc.0.0403323(Journal)